NCT06038318 is a NA clinical trial of PRISM Program Video Coach in Stress, sponsored by Dana-Farber Cancer Institute.

Who is sponsoring NCT06038318?

NCT06038318 is sponsored by Dana-Farber Cancer Institute.

What drugs are being tested in NCT06038318?

Interventions in NCT06038318: PRISM Program Video Coach, PRISM Program Text Coach, mPRISM Program App.

What condition does NCT06038318 study?

NCT06038318 studies Stress, Anxiety.

Is NCT06038318 still recruiting?

NCT06038318 is currently recruiting now. Last updated 29 December 2025.

Last reviewed 2025-12-29 · How we verify

NCT06038318

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer

Recruiting now NA Last updated 29 December 2025

What this trial tests

NA trial testing PRISM Program Video Coach in Stress in 325 participants. Currently enrolling.

Timeline

16 October 2023

Primary endpoint
31 December 2026

1 May 2027

Quick facts

Lead sponsor	Dana-Farber Cancer Institute
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	none
Primary purpose	health services research
Enrollment	325
Start date	16 October 2023
Primary completion	31 December 2026
Estimated completion	1 May 2027
Sites	2 locations across United States

Drugs / interventions tested

PRISM Program Video Coach
PRISM Program Text Coach
mPRISM Program App

Conditions studied

Stress — all drugs for Stress →
Anxiety — all drugs for Anxiety →

Sponsor

Dana-Farber Cancer Institute

Who can join

Adults 12 to 25, any sex, with Stress or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to find the best way to help participants and families manage the stress of facing a serious illness and be better able to "bounce back" or be resilient after a difficult situation. Participants will take part in the "Promoting Resilience in Stress Management" PRISM program, which is designed to provide skills to change or improve the impact of stress in everyday life. The name of the intervention used in this research study is: -PRISM (a mobile app program comprised of 6 sessions of skills-based, manualized resilience education)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Fostering resilience in adolescence and young adulthood: Considerations for evidence-based, patient-centered oncology care.
Salsman JM, Rosenberg AR. · · 2024 · cited 13× · PMID 38163249 · DOI 10.1002/cncr.35182

Verify or expand the search:

Other recruiting trials for Stress

Currently open trials in the same condition.

NCT07485790 — The Effects of Yoga on Pregnant Women · NA · recruiting
NCT07469527 — Effects of Feel Free® Classic Tonic on Stress and Pharmacokinetics in Healthy Adults · NA · recruiting
NCT07387107 — Decreasing Stress Via Virtual Reality and Binaural Beats in Non-Clinical Adults · NA · recruiting
NCT07240792 — Development of a College Student-Delivered Cognitive-Behavioral Therapy (CBT) Intervention for Rural High School Student · NA · recruiting
NCT07518056 — Relationships Between Nomophobia Levels and Perceived Stress, Body Image and Food Addiction Among University Students · recruiting

Other Dana-Farber Cancer Institute trials

Trials by the same sponsor.

NCT07519200 — Sexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational Intervention · NA · not yet recruiting
NCT07499999 — Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk fo · Phase 2 · not yet recruiting
NCT05825469 — Development and Testing of Nutritional Algorithms (NACHO) · NA · not yet recruiting
NCT07516353 — my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults · NA · not yet recruiting
NCT07513324 — Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06038318 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dana-Farber Cancer Institute
Last refreshed: 29 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06038318.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing